Preferably, the antibody is a polyclonal antibody raised against acrolein-modified KLH. Alternatively, the determination of the ability of a test molecule to reduce the concentration of one or more acrolein-modified proteins may be by a method that includes determination of the concentration of acrolien-modified proteins by mass spectrometry to detect adducts in the modified proteins.